NDC 0641-6080-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6080
- Requested NDC
- 0641-6080-01
- Package NDCs from labels
- 0641-6080-01, 0641-6080-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2026-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2026-04-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Ondansetron - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2025-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6080-01 | Ondansetron | 2 mL in 1 VIAL | INJECTION | 2 | 20 | |
| 0641-6080-25 | Ondansetron | 25 in 1 CARTON | INJECTION | 25 | 20 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6080-01 | ML - Milliliter | 0641-6080 | 3ecda475-6cd1-4288-a0ec-a84a0d8d4fff | 1 | 2012-07-24 |
| 0641-6080-25 | ML - Milliliter | 0641-6080 | 5d18bfb7-bded-4583-a5b2-da3b0433d322 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Aurobindo Pharma Limited | cf10d256-dd89-4a91-a3ed-81db505a79c2 | 2025-07-08 | Warnings, Adverse reactions | NMH84OZK2B |
| Schuessler Tissue Salts Nat Mur Fluid Balance 9 | NATRUM MURIATICUM | Martin & Pleasance Pty Ltd | 0b21c366-fff6-4754-a671-35481ec2c4bd | 2025-07-07 | Warnings | 451W47IQ8X |
| Normal Salt | SODIUM CHLORIDE | Twin Med LLC | dc82ff0f-8600-373a-e053-2995a90a7505 | 2025-07-03 | Warnings | 451W47IQ8X |
| Sodium Chloride Normal Salt | SODIUM CHLORIDE | Advanced Rx LLC | 40f471b7-27cf-4ad4-aef6-cc9d0623ddd9 | 2025-07-02 | Warnings | 451W47IQ8X |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 0956bd7c-d46f-483a-bf2c-9e11c6111ebf | 2025-07-02 | 451W47IQ8X | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b79ef556-37b3-4fd0-8589-c633033be9df | 2025-07-02 | 451W47IQ8X | |
| Parasode | ARTEMISIA VULGARIS ROOT, CHELIDONIUM MAJUS WHOLE, PUNICA GRANATUM ROOT BARK, SPIGELIA ANTHELMIA WHOLE, KRAMERIA LAPPACEA ROOT, ARSENIC TRIOXIDE, IRON, OYSTER SHELL CALCIUM CARBONATE, CRUDE, ARTEMISIA CINA PRE-FLOWERING TOP, SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS, GRAPHITE, CALOMEL, SODIUM CHLORIDE, AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Zorex | 0ed722dc-cd25-4a15-b3f8-052cc7bcd9ec | 2025-07-01 | Warnings | 451W47IQ8X |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | d5b85158-b0d6-4855-9d07-8d1b3ad9ab71 | 2025-06-30 | Warnings, Adverse reactions | 451W47IQ8X |
| ONDANSETRON | ONDANSETRON HYDROCHLORIDE | Dr. Reddy's Laboratories Limited | 162f2088-9fb1-47e7-b88c-45104be7e7bb | 2025-06-30 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE | Baxter Healthcare Corporation | 729d865f-d84a-495e-9456-4bceebb6e03f | 2025-06-30 | Warnings, Adverse reactions | 283504 1740467 NMH84OZK2B |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 958d35f0-6834-43be-a700-fa58f38b4c19 | 2025-06-30 | Warnings, Adverse reactions | 451W47IQ8X |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | 451W47IQ8X B22547B95K |
| Nauzene Chewables Ginger Honey | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | 25c9825d-a4e8-4671-e063-6294a90ab46d | 2025-06-24 | Warnings | B22547B95K |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | ee1f115f-c8f8-4526-b827-c8e48aeb5050 | 2025-06-20 | Warnings, Adverse reactions | ANDA077541 55154-2876-5 55154-2876 1740467 5f4e1ec0-a5ac-4196-9df2-86de29a55533 ee1f115f-c8f8-4526-b827-c8e48aeb5050 NMH84OZK2B |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 92c758a3-e749-4a15-be4b-ee30b364b2b0 | 2025-06-12 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 1a0c4dc6-643e-4ee7-92a9-edb98049a5ba | 2025-06-09 | Warnings, Adverse reactions | NMH84OZK2B |
| HAIR STIM | PEDICULUS CAPITIS, THYROIDINUM (SUIS), BARYTA CARBONICA, BORAX, CALCAREA CARBONICA, CINCHONA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HYDROFLUORICUM ACIDUM, MERCURIUS SOLUBILIS, MEZEREUM, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, SILICEA, SULPHUR, THUJA OCCIDENTALIS, VINCA MINOR | The Wellness Center for Research and Education, Inc. | 8ecc05ff-ed5a-4157-9100-1c7912686f07 | 2025-06-06 | Warnings | 451W47IQ8X |
| MBM 7 Lung | COCCUS CACTI, LUNG (SUIS), IGNATIA AMARA, CAUSTICUM, NATRUM MURIATICUM | The Wellness Center for Research and Education, Inc. | 6eb49fb5-485c-4b48-b231-4db88ebe20df | 2025-06-04 | Warnings | 451W47IQ8X |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.